What is TILRAY BRANDS INC's earnings per share (EPS)?

TILRAY BRANDS INC (TLRY) reported diluted earnings per share of -$1.09 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

TILRAY BRANDS INC Financials

TLRY

FY2026 annual

Revenue $915.5M +11.5% YoY

Net Income -$121.4M +94.4% YoY

EPS (Diluted) -$1.09 YoY not available

Free Cash Flow Not reported for FY2026

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended May 31, 2026 Reported Jul 28, 2026 Currency USD FYE May

TILRAY BRANDS INC (TLRY) reported $915.5M in revenue for fiscal year 2026, up 11.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TLRY FY2026 2026-08-15

Gross-margin expansion is visible, but operating costs and working capital still consume cash despite higher revenue.

From FY2022 to FY2026, gross margin widened from 18.6% to 28.5%, yet the business remained loss-making because operating expenses and other operating charges absorbed most gross profit. In FY2026, the $121M net loss exceeded the $69M operating cash outflow, indicating that reported earnings included costs that did not consume equivalent current-period cash.

FY2026 revenue reached $915M, while operating losses narrowed to $63M from $2.3B in FY2025; the improvement points to a sharp reversal in operating charges, not merely incremental sales leverage. Gross margin remained near its FY2024-FY2025 level, so the main change was below gross profit.

Cash stayed close to $226M while accounts receivable and inventory rose to $189M and $301M, respectively. That combination suggests more capital is tied up in customers and stock, helping explain why operating cash flow remained negative even as the current ratio was 2.2x.

Financial Health Signals

Financial Health Score 38/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of TILRAY BRANDS INC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

TILRAY BRANDS INC has an operating margin of -6.9%, meaning the company loses $7 on every $100 of revenue. This results in a profitability score of 17/100. This is up from -277.9% the prior year.

Growth

TILRAY BRANDS INC's revenue grew 11.5% year-over-year to $915.5M, a solid pace of expansion. This earns a growth score of 59/100.

Leverage

TILRAY BRANDS INC has a moderate D/E ratio of 0.45. This balance of debt and equity financing earns a leverage score of 61/100.

Liquidity

TILRAY BRANDS INC's current ratio of 2.21 indicates adequate short-term liquidity, earning a score of 63/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Returns

TILRAY BRANDS INC posts a -7.5% return on equity (ROE), meaning it loses $8 for every $100 of shareholders' equity. This results in a returns score of 15/100. This is up from -144.7% the prior year.

Altman Z-Score Distress

-1.95

TILRAY BRANDS INC scores -1.95, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($628.7M) relative to total liabilities ($733.1M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

3/8

TILRAY BRANDS INC passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

TILRAY BRANDS INC reported a net loss of $121.4M while operations used $69.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

TILRAY BRANDS INC reported an operating loss of $63.0M against $29.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$915.5M

YoY+11.5%

5Y CAGR+12.3%

TILRAY BRANDS INC generated $915.5M in revenue in fiscal year 2026. This represents an increase of 11.5% from the prior year.

Net Income

-$121.4M

YoY+94.4%

TILRAY BRANDS INC reported -$121.4M in net income in fiscal year 2026. This represents an increase of 94.4% from the prior year.

EPS (Diluted)

-$1.09

TILRAY BRANDS INC earned -$1.09 per diluted share (EPS) in fiscal year 2026.

EBITDA

Not reported for fiscal year 2026.

Cash & Balance Sheet

Cash & Debt

$226.0M

YoY+1.9%

5Y CAGR-14.3%

TILRAY BRANDS INC held $226.0M in cash as of fiscal year 2026; long-term debt is not reported for that period.

Shares Outstanding

136M

TILRAY BRANDS INC had 136M shares outstanding in fiscal year 2026.

Free Cash Flow

Not reported for fiscal year 2026.

Dividends Per Share

Not reported for fiscal year 2026.

Margins & Returns

Gross Margin

28.4%

YoY-0.8pp

5Y CAGR+23.6pp

TILRAY BRANDS INC's gross margin was 28.4% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 0.8 percentage points from the prior year.

Operating Margin

-6.9%

5Y CAGR+32.3pp

TILRAY BRANDS INC's operating margin was -6.9% in fiscal year 2026, reflecting core business profitability. No change is given against fiscal year 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

-13.3%

5Y CAGR+39.6pp

TILRAY BRANDS INC's net profit margin was -13.3% in fiscal year 2026, showing the share of revenue converted to profit. No change is given against fiscal year 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

-7.5%

YoY+137.2pp

5Y CAGR-1.4pp

TILRAY BRANDS INC's ROE was -7.5% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 137.2 percentage points from the prior year.

Capital Allocation

R&D Spending

$361K

YoY+27.1%

5Y CAGR-39.4%

TILRAY BRANDS INC invested $361K in research and development in fiscal year 2026. This represents an increase of 27.1% from the prior year.

Share Buybacks

Not reported for fiscal year 2026.

Capital Expenditures

Not reported for fiscal year 2026.

TLRY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TLRY quarterly income statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY17	FY16
Revenue	$915.5M+11.5%	$821.3M+4.1%	$788.9M+25.8%	$627.1M-0.2%	$628.4M+22.5%	$513.1M+26.6%	$405.3M+126.1%	$179.3M	$20.5M+62.4%	$12.6M
Cost of Revenue	$655.0M+12.8%	$580.7M+2.7%	$565.6M+17.8%	$480.2M-6.1%	$511.6M+175.3%	$185.8M-2.4%	$190.5M+560.1%	$28.9M	$9.2M-8.2%	$10.0M
Gross Profit	$260.4M+8.3%	$240.6M+7.7%	$223.4M+52.0%	$147.0M+25.8%	$116.8M+373.8%	$24.7M-88.5%	$214.9M+1405.1%	$14.3M	$11.4M+326.1%	$2.7M
R&D Expenses	$361K+27.1%	$284K-55.3%	$635K-6.9%	$682K-55.1%	$1.5M-65.6%	$4.4M-51.9%	$9.2M+56.4%	$5.9M	$3.2M+179.1%	$1.1M
SG&A Expenses	$203.6M+21.7%	$167.3M0.0%	$167.4M+1.3%	$165.2M+1.4%	$162.8M+89.6%	$85.9M-22.6%	$110.9M+128.3%	$48.6M	$7.5M+53.4%	$4.9M
Operating Income	-$63.0M+97.2%	-$2.3B-1206.3%	-$174.7M+87.2%	-$1.4B-124.4%	-$610.4M-203.5%	-$201.1M+33.9%	-$304.1M-425.8%	-$57.8M	-$7.5M-6.4%	-$7.0M
Interest Expense	$29.9M-27.6%	$41.3M-16.1%	$49.3M+5.7%	$46.6M+17.5%	$39.7M+28.4%	$30.9M+20.5%	$25.6M+352.4%	$5.7M	$693K-10.2%	$772K
Income Tax	$17.1M+114.1%	-$121.0M-354.7%	-$26.6M-270.6%	-$7.2M-9.8%	-$6.5M-16.8%	-$5.6M+33.7%	-$8.4M-89.8%	-$4.5M	N/A	N/A
Net Income	-$121.4M+94.4%	-$2.2B-792.6%	-$245.0M+83.1%	-$1.5B-204.7%	-$476.8M-75.9%	-$271.1M+15.6%	-$321.2M-374.2%	-$67.7M	-$7.8M+0.9%	-$7.9M
EPS (Diluted)	-$1.09	-$24.56-644.2%	-$3.30	-$2.35-137.4%	-$0.99	-$1.36	-$0.47	-$0.18	N/A	N/A

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Revenue	$281.7M+36.3%	$206.7M-5.0%	$217.5M+3.8%	$209.5M-6.7%	$224.5M+20.9%	$185.8M-11.9%	$210.9M+5.5%	$200.0M
Cost of Revenue	$191.2M+26.0%	$151.8M-5.1%	$160.0M+5.2%	$152.0M-3.1%	$156.9M+17.3%	$133.8M-10.7%	$149.7M+6.7%	$140.3M
Gross Profit	$90.5M+64.7%	$55.0M-4.4%	$57.5M0.0%	$57.5M-15.0%	$67.6M+30.0%	$52.0M-15.0%	$61.2M+2.5%	$59.7M
R&D Expenses	$180K+190.3%	$62K-20.5%	$78K+90.2%	$41K+20.6%	$34K-60.0%	$85K+41.7%	$60K-42.9%	$105K
SG&A Expenses	$61.2M+21.8%	$50.2M-1.9%	$51.2M+24.7%	$41.1M+8.1%	$38.0M-3.3%	$39.2M-14.7%	$46.0M+4.3%	$44.1M
Operating Income	-$16.5M+37.6%	-$26.4M-18.4%	-$22.3M-1165.0%	$2.1M+100.1%	-$1.4B-90.0%	-$759.9M-1700.0%	-$42.2M-15.4%	-$36.6M
Income Tax	$13.9M+602.3%	$2.0M-44.3%	$3.5M+255.2%	-$2.3M+98.2%	-$125.1M-10502.5%	$1.2M-40.9%	$2.0M+129.8%	$886K
Net Income	-$49.6M-86.6%	-$26.6M+40.9%	-$44.9M-13853.7%	-$322K+100.0%	-$1.3B-61.2%	-$789.4M-825.0%	-$85.3M-117.9%	-$39.2M
EPS (Diluted)	-$0.44-83.3%	-$0.24+41.5%	-$0.41	$0.00+100.0%	-$1.40	-$8.69-777.8%	-$0.99	-$0.04

Not reported in any period shown, so not listed: Interest Expense.

TLRY Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TLRY quarterly balance sheet

Metric	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY17	FY16
Total Assets	$2.3B+12.2%	$2.1B-50.9%	$4.2B-2.0%	$4.3B-21.0%	$5.4B-9.6%	$6.0B+604.1%	$855.7M-16.4%	$1.0B	$53.9M	N/A
Current Assets	$792.1M+15.0%	$688.6M+1.6%	$677.7M-12.3%	$773.0M-3.8%	$803.5M-9.1%	$883.6M+204.9%	$289.8M-19.2%	$358.6M	$12.4M	N/A
Cash & Equivalents	$226.0M+1.9%	$221.7M-2.9%	$228.3M+10.5%	$206.6M-50.3%	$415.9M-14.9%	$488.5M+256.0%	$137.2M-25.7%	$184.6M	$2.3M-69.2%	$7.5M
Inventory	$301.2M+11.2%	$270.9M+7.5%	$252.1M+25.7%	$200.6M-18.3%	$245.5M-4.3%	$256.4M+175.5%	$93.1M+23.6%	$75.3M	$7.4M	N/A
Accounts Receivable	$189.2M+55.7%	$121.5M+19.5%	$101.7M+17.9%	$86.2M-9.5%	$95.3M+9.1%	$87.3M+228.1%	$26.6M+8.1%	$24.6M	$983K	N/A
Goodwill	$752.4M0.0%	$752.4M-62.5%	$2.0B0.0%	$2.0B-23.9%	$2.6B-6.8%	$2.8B+1711.6%	$156.4M+0.9%	$155.0M	N/A	N/A
Total Liabilities	$733.1M+25.4%	$584.8M-24.9%	$778.5M-20.3%	$977.3M-3.1%	$1.0B-35.4%	$1.6B+115.4%	$724.2M+9.1%	$664.0M	$58.8M	N/A
Current Liabilities	$358.4M+27.9%	$280.3M-6.3%	$299.2M-30.9%	$433.0M+54.4%	$280.3M-30.1%	$401.2M+145.2%	$163.7M-7.0%	$175.9M	$50.2M	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	$117.9M-29.6%	$167.5M+78.1%	$94.0M	N/A	$9.4M	N/A
Total Equity	$1.6B+6.8%	$1.5B-56.1%	$3.4B+3.8%	$3.3B-24.6%	$4.4B-1.4%	$4.5B+3291.3%	$131.5M-63.5%	$360.1M	-$4.9M-291.9%	$2.5M
Retained Earnings	-$5.0B-2.5%	-$4.8B-82.2%	-$2.7B-10.1%	-$2.4B-150.9%	-$962.9M-98.1%	-$486.1M+32.9%	-$724.8M-317.7%	-$173.5M	-$40.5M	N/A

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Total Assets	$2.3B+12.2%	$2.1B0.0%	$2.1B-0.4%	$2.1B+0.4%	$2.1B	N/A	$3.4B-20.1%	$4.3B
Current Assets	$792.1M+10.2%	$718.8M+4.4%	$688.6M-1.8%	$701.1M+1.8%	$688.6M	N/A	$686.3M-5.5%	$725.9M
Cash & Equivalents	$226.0M+10.4%	$204.6M-7.7%	$221.7M-16.3%	$264.8M+19.5%	$221.7M	N/A	$200.0M-2.5%	$205.2M
Inventory	$301.2M+3.0%	$292.3M+7.9%	$270.9M-4.2%	$282.8M+4.4%	$270.9M+2.8%	$263.4M0.0%	$263.4M-0.3%	$264.3M
Accounts Receivable	$189.2M+59.8%	$118.4M-2.6%	$121.5M+13.5%	$107.1M-11.9%	$121.5M	N/A	$103.4M-0.6%	$104.0M
Goodwill	$752.4M0.0%	$752.4M0.0%	$752.4M0.0%	$752.4M0.0%	$752.4M-42.1%	$1.3B0.0%	$1.3B-35.3%	$2.0B
Total Liabilities	$733.1M+33.5%	$549.1M-6.1%	$584.8M+4.1%	$562.0M-3.9%	$584.8M	N/A	$701.0M-9.9%	$778.5M
Current Liabilities	$358.4M+39.2%	$257.5M-8.1%	$280.3M+4.7%	$267.6M-4.5%	$280.3M	N/A	$262.2M-10.7%	$293.5M
Total Equity	$1.6B+3.7%	$1.6B+3.0%	$1.5B-1.9%	$1.5B+1.9%	$1.5B-44.1%	$2.7B-1.0%	$2.7B-21.5%	$3.5B
Retained Earnings	-$5.0B-1.0%	-$4.9B-1.5%	-$4.8B0.0%	-$4.8B0.0%	-$4.8B	N/A	-$3.6B-32.4%	-$2.7B

Not reported in any period shown, so not listed: Long-Term Debt.

TLRY Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TLRY quarterly cash flow statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY17	FY16
Operating Cash Flow	-$69.1M+26.9%	-$94.6M-206.1%	-$30.9M-490.9%	$7.9M+104.5%	-$177.3M-37.0%	-$129.4M+49.9%	-$258.1M-458.0%	-$46.2M	-$6.0M-80.9%	-$3.3M
Capital Expenditures	N/A	$32.9M+12.5%	$29.2M+40.6%	$20.8M-38.9%	$34.1M-23.7%	$44.6M-39.5%	$73.7M+46.9%	$50.2M	$10.9M+2135.7%	$488K
Free Cash Flow	N/A	-$127.5M-112.0%	-$60.2M-366.5%	-$12.9M+93.9%	-$211.3M-21.5%	-$174.0M+47.6%	-$331.8M-244.0%	-$96.4M	-$16.9M-344.4%	-$3.8M
Investing Cash Flow	-$55.8M-19.4%	-$46.7M-136.4%	$128.3M+145.0%	-$285.1M-1224.1%	-$21.5M+48.3%	-$41.7M+83.5%	-$253.2M-156.7%	-$98.6M	-$11.8M-1052.7%	-$1.0M
Financing Cash Flow	$131.0M-1.9%	$133.5M+277.6%	-$75.2M-207.2%	$70.2M-45.3%	$128.2M-51.6%	$264.8M+130.9%	$114.7M-81.8%	$631.0M	$12.2M+12.1%	$10.9M

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Operating Cash Flow	-$37.3M-70.1%	-$21.9M-157.0%	-$8.5M-536.6%	-$1.3M+89.5%	-$12.8M-122.3%	-$5.8M+85.9%	-$40.7M-15.3%	-$35.3M
Capital Expenditures	N/A	N/A	N/A	N/A	$6.3M-56.1%	$14.4M+165.2%	$5.4M-19.3%	$6.7M
Free Cash Flow	N/A	N/A	N/A	N/A	-$19.1M+5.1%	-$20.2M+56.3%	-$46.2M-9.8%	-$42.0M
Investing Cash Flow	-$51.2M-277.0%	$28.9M+149.9%	-$58.0M-337.1%	$24.5M+81.0%	$13.5M+11462.2%	-$119K+98.9%	-$10.7M+78.3%	-$49.4M
Financing Cash Flow	$68.2M+1429.4%	-$5.1M-110.7%	$48.1M+142.3%	$19.8M+19.3%	$16.6M-7.9%	$18.1M-52.7%	$38.2M-36.9%	$60.6M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

TLRY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

TLRY quarterly financial ratios

Metric	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY17	FY16
Gross Margin	28.4%-0.8pp	29.3%+1.0pp	28.3%+4.9pp	23.4%+4.8pp	18.6%+13.8pp	4.8%-48.2pp	53.0%+45.0pp	8.0%	55.4%+34.3pp	21.1%
Operating Margin	-6.9%	-277.9%	-22.1%	-218.4%	-97.1%-57.9pp	-39.2%+35.8pp	-75.0%-42.8pp	-32.3%	-36.5%+19.2pp	-55.8%
Net Margin	-13.3%	-266.3%	-31.1%	-231.6%	-75.9%-23.1pp	-52.8%+26.4pp	-79.2%-41.5pp	-37.8%	-38.0%+24.3pp	-62.4%
Return on Equity	-7.5%+137.2pp	-144.7%-137.6pp	-7.1%+36.7pp	-43.8%-33.0pp	-10.8%-4.8pp	-6.1%+238.2pp	-244.3%-225.5pp	-18.8%	N/A	-311.8%
Return on Assets	-5.2%+100.2pp	-105.4%-99.6pp	-5.8%+27.9pp	-33.7%-25.0pp	-8.8%-4.3pp	-4.5%+33.0pp	-37.5%-30.9pp	-6.6%	-14.5%	N/A
Current Ratio	2.21-0.2x	2.46+0.2x	2.27+0.5x	1.79-1.1x	2.87+0.7x	2.20+0.4x	1.77-0.3x	2.04	0.25	N/A
Debt-to-Equity	0.45+0.1x	0.39+0.2x	0.23-0.1x	0.29+0.3x	0.030.0x	0.04-0.7x	0.72-1.1x	1.84	N/A	N/A
FCF Margin	N/A	-15.5%-7.9pp	-7.6%-5.6pp	-2.1%+31.6pp	-33.6%+0.3pp	-33.9%+47.9pp	-81.9%-28.1pp	-53.8%	-82.3%-52.3pp	-30.1%

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Gross Margin	32.1%+5.5pp	26.6%+0.2pp	26.4%-1.0pp	27.4%-2.7pp	30.1%+2.1pp	28.0%-1.0pp	29.0%-0.8pp	29.8%
Operating Margin	-5.8%+6.9pp	-12.8%-2.5pp	-10.2%-11.2pp	1.0%	-643.1%	-409.0%	-20.0%-1.7pp	-18.3%
Net Margin	-17.6%-4.7pp	-12.8%+7.8pp	-20.7%-20.5pp	-0.1%	-566.9%	-424.9%	-40.5%-20.9pp	-19.6%
Return on Equity	-3.1%-1.4pp	-1.7%+1.3pp	-3.0%-3.0pp	0.0%+84.2pp	-84.2%-55.0pp	-29.2%-26.1pp	-3.1%-2.0pp	-1.1%
Return on Assets	-2.1%-0.8pp	-1.3%+0.9pp	-2.2%-2.2pp	0.0%+61.3pp	-61.4%	N/A	-2.5%-1.6pp	-0.9%
Current Ratio	2.21-0.6x	2.79+0.3x	2.46-0.2x	2.62+0.2x	2.46	N/A	2.62+0.1x	2.47
Debt-to-Equity	0.45+0.1x	0.350.0x	0.390.0x	0.360.0x	0.39	N/A	0.260.0x	0.22
FCF Margin	N/A	N/A	N/A	N/A	-8.5%+2.3pp	-10.9%+11.0pp	-21.9%-0.9pp	-21.0%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Similar Companies

Amphastar Pharma AMPH

$936.7M

Evotec Ag EVO

$693.0M

Dynavax Technolo DVAX

$1.8B

Harrow Health Inc HROW

$1.5B

Pacira Biosciences Inc PCRX

$1.0B

Where TILRAY BRANDS INC Ranks

Frequently Asked Questions

What is TILRAY BRANDS INC's annual revenue?

TILRAY BRANDS INC (TLRY) reported $915.5M in total revenue for fiscal year 2026. This represents a 11.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is TILRAY BRANDS INC's revenue growing?

TILRAY BRANDS INC (TLRY) revenue grew by 11.5% year-over-year, from $821.3M to $915.5M in fiscal year 2026.

Is TILRAY BRANDS INC profitable?

No, TILRAY BRANDS INC (TLRY) reported a net income of -$121.4M in fiscal year 2026, with a net profit margin of -13.3%.

What is TILRAY BRANDS INC's gross margin?

TILRAY BRANDS INC (TLRY) had a gross margin of 28.4% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is TILRAY BRANDS INC's operating margin?

TILRAY BRANDS INC (TLRY) had an operating margin of -6.9% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is TILRAY BRANDS INC's net profit margin?

TILRAY BRANDS INC (TLRY) had a net profit margin of -13.3% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is TILRAY BRANDS INC's return on equity (ROE)?

TILRAY BRANDS INC (TLRY) has a return on equity of -7.5% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is TILRAY BRANDS INC's operating cash flow?

TILRAY BRANDS INC (TLRY) recorded an outflow of $69.1M in operating cash flow during fiscal year 2026, representing cash used by core business activities.

What are TILRAY BRANDS INC's total assets?

TILRAY BRANDS INC (TLRY) had $2.3B in total assets as of fiscal year 2026, including both current and long-term assets.

How much does TILRAY BRANDS INC spend on research and development?

TILRAY BRANDS INC (TLRY) invested $361K in research and development during fiscal year 2026.

How many shares does TILRAY BRANDS INC have outstanding?

TILRAY BRANDS INC (TLRY) had 136M shares outstanding as of fiscal year 2026.

What is TILRAY BRANDS INC's current ratio?

TILRAY BRANDS INC (TLRY) had a current ratio of 2.21 as of fiscal year 2026, which is generally considered healthy.

What is TILRAY BRANDS INC's debt-to-equity ratio?

TILRAY BRANDS INC (TLRY) had a debt-to-equity ratio of 0.45 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is TILRAY BRANDS INC's return on assets (ROA)?

TILRAY BRANDS INC (TLRY) had a return on assets of -5.2% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

How does TILRAY BRANDS INC's liquidity compare with its operating cash outflow?

At the end of fiscal year 2026, TILRAY BRANDS INC (TLRY) held $237.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $69.1M over that year. Dividing the one by the other, the reported balance equals about 41 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is TILRAY BRANDS INC's Altman Z-Score?

TILRAY BRANDS INC (TLRY) has an Altman Z-Score of -1.95, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is TILRAY BRANDS INC's Piotroski F-Score?

TILRAY BRANDS INC (TLRY) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are TILRAY BRANDS INC's earnings high quality?

TILRAY BRANDS INC (TLRY) reported a net loss of $121.4M while operations used $69.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can TILRAY BRANDS INC cover its interest payments?

TILRAY BRANDS INC (TLRY) reported an operating loss of $63.0M against $29.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is TILRAY BRANDS INC?

TILRAY BRANDS INC (TLRY) scores 38 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.